YU295877A - Process for obtaining therepeutically active piperazine derivatives - Google Patents

Process for obtaining therepeutically active piperazine derivatives

Info

Publication number
YU295877A
YU295877A YU02958/77A YU295877A YU295877A YU 295877 A YU295877 A YU 295877A YU 02958/77 A YU02958/77 A YU 02958/77A YU 295877 A YU295877 A YU 295877A YU 295877 A YU295877 A YU 295877A
Authority
YU
Yugoslavia
Prior art keywords
therepeutically
obtaining
piperazine derivatives
active piperazine
active
Prior art date
Application number
YU02958/77A
Other languages
English (en)
Inventor
J Gootjes
Original Assignee
Gist Brocades Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades Nv filed Critical Gist Brocades Nv
Priority to YU189182A priority Critical patent/YU189182A/xx
Priority to YU189282A priority patent/YU189282A/xx
Publication of YU295877A publication Critical patent/YU295877A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
YU02958/77A 1976-12-14 1977-12-14 Process for obtaining therepeutically active piperazine derivatives YU295877A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
YU189182A YU189182A (en) 1976-12-14 1982-08-23 Process for obtaining therapeutically active piperazine derivatives
YU189282A YU189282A (en) 1976-12-14 1982-08-23 Process for obtaining new therapeutically active piperazine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB52223/76A GB1545094A (en) 1976-12-14 1976-12-14 Piperazine derivatives

Publications (1)

Publication Number Publication Date
YU295877A true YU295877A (en) 1983-01-21

Family

ID=10463103

Family Applications (1)

Application Number Title Priority Date Filing Date
YU02958/77A YU295877A (en) 1976-12-14 1977-12-14 Process for obtaining therepeutically active piperazine derivatives

Country Status (22)

Country Link
US (2) US4202896A (xx)
JP (1) JPS5382789A (xx)
AT (1) AT363090B (xx)
AU (1) AU516920B2 (xx)
BE (1) BE861853A (xx)
DE (1) DE2755752A1 (xx)
DK (1) DK147421C (xx)
ES (6) ES465047A1 (xx)
FI (1) FI69839C (xx)
GB (1) GB1545094A (xx)
HU (1) HU177999B (xx)
IE (1) IE46278B1 (xx)
IL (1) IL53597A0 (xx)
IT (1) IT1093045B (xx)
LU (1) LU78686A1 (xx)
NL (1) NL7713817A (xx)
NO (1) NO148150C (xx)
NZ (1) NZ185981A (xx)
PT (1) PT67400B (xx)
SE (1) SE435378B (xx)
YU (1) YU295877A (xx)
ZA (1) ZA777452B (xx)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU546260B2 (en) * 1980-06-16 1985-08-22 Ferrosan A.B. Diphenylbutyl-1-acylpiperazines
NL8202636A (nl) * 1982-06-29 1984-01-16 Gist Brocades Nv Piperazinederivaten, werkwijzen ter bereiding daarvan en farmaceutische preparaten die deze verbindingen bevatten.
DE3600390A1 (de) * 1986-01-09 1987-07-16 Hoechst Ag Diarylalkyl-substituierte alkylamine, verfahren zu ihrer herstellung, ihre verwendung sowie sie enthaltende arzneimittel
US5162537A (en) * 1986-04-17 1992-11-10 Monsanto Company Benzhydryl compounds as herbicide antidotes
HU196194B (en) * 1986-04-28 1988-10-28 Richter Gedeon Vegyeszet Process for producing new 1-4 disubstituted piperazines and pharmaceuticals comprising the compounds
HU196195B (en) * 1986-04-28 1988-10-28 Richter Gedeon Vegyeszet Process for producing 1,4-disubstituted piperazine derivatives and pharmaceuticals comprising the compounds
HU196196B (en) * 1986-04-28 1988-10-28 Richter Gedeon Vegyeszet Process for producing new benzhydryl-piperazine derivatives and pharmaceuticals comprising the compounds
FR2601366B1 (fr) * 1986-07-10 1988-11-25 Andre Buzas Derives de la benzhydryloxyethyl-piperazine, procedes d'obtention et de compositions pharmaceutiques les contenant.
FR2636946B1 (fr) * 1988-09-23 1990-11-02 Lipha ((diarylmethoxy)alcoyl)-1 pyrrolidines et piperidines, procedes de preparation et medicaments les contenant
US5153198A (en) * 1989-03-15 1992-10-06 Santen Pharmaceutical Co., Ltd. Agent for treatment of disorders of the cerebro-neural transmission system
US5087627A (en) * 1989-03-15 1992-02-11 Santen Pharmaceutical Co., Ltd. Agent for treatment of disorders of the cerebro-neural transmission system
FR2661176B1 (fr) * 1990-04-20 1992-06-12 Adir Nouveau procede de preparation de la 1-(2,3,4-trimethoxybenzyl) piperazine en amination reductive.
US5276035A (en) * 1990-07-26 1994-01-04 Novo Nordisk A/S 1,4-disubstituted piperazines
DK178490D0 (da) * 1990-07-26 1990-07-26 Novo Nordisk As 1,4-disubstituerede piperaziner
WO1993000811A1 (en) * 1991-07-01 1993-01-21 The General Hospital Corporation Invertebrate phenylethanolamine transporter and the use thereof
ES2157258T3 (es) * 1993-06-25 2001-08-16 Pola Chem Ind Inc Inhibidores de la reincorporacion de dopamina destinados para el tratamiento del sindrome de parkinson.
CA2396956C (en) * 2000-01-11 2010-10-26 Biostream Therapeutics, Inc. Polypharmacophoric agents
US6743797B2 (en) 2002-02-22 2004-06-01 Chantest, Inc. Methods for treating cardiac arrhythmia
US20050054010A1 (en) * 2003-07-15 2005-03-10 Brown Arthur M. High throughput assay systems and methods for identifying agents that alter surface expression of integral membrane proteins
US7211407B2 (en) * 2003-07-15 2007-05-01 Chan Test, Inc. High throughput assay systems and methods for identifying agents that alter surface expression of integral membrane proteins
US20050208595A1 (en) * 2004-03-19 2005-09-22 Brown Arthur M High throughput assay systems and methods for identifying agents that alter expression of cellular proteins
FR2884712B1 (fr) * 2005-04-21 2007-06-15 Oreal Compositions cosmetiques comprenant des derives de piperazine
AU2006264966B2 (en) 2005-07-04 2013-02-21 High Point Pharmaceuticals, Llc Histamine H3 receptor antagonists
EP2038256A1 (en) * 2006-05-23 2009-03-25 TransTech Pharma, Inc 6- (4-cyclopropylpiperazin-1-yl) -2 ' -methyl- [3, 4 ']-bipyridine and its use as a medicament
CA2659570C (en) * 2006-05-29 2015-10-06 High Point Pharmaceuticals, Llc 3-(1,3-benzodioxol-5-yl)-6-(4-cyclopropylpiperazin-1-yl)-pyridazine, its salts and solvates and its use as histamine h3 receptor antagonist
EP2014656A3 (en) * 2007-06-11 2011-08-24 High Point Pharmaceuticals, LLC New heteocyclic h3 antagonists
US20120028992A1 (en) * 2010-08-02 2012-02-02 Brown Arthur M Pharmaceutical compositions for terminating acute episodes of cardiac arrhythmia, restoring sinus rhythm, preventing recurrence of cardiac arrhythmia and/or maintaining normal sinus rhythm in mammals
CN104529942B (zh) * 2014-12-10 2018-05-15 天津孚音生物科技发展有限公司 一种伐诺司林的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB837986A (en) 1956-07-10 1960-06-22 Henri Morren New piperazine derivatives and process for the preparation thereof
US2953568A (en) * 1958-03-03 1960-09-20 Ciba Pharm Prod Inc Derivatives of piperazine
CH410961A (de) * 1961-02-22 1966-04-15 Yoshitomi Pharmaceutical Verfahren zur Herstellung N-substituierter Piperazinderivate
DE1445692A1 (de) 1963-03-25 1969-03-20 Egyt Gyogyszervegyeszeti Gyar Verfahren zur Herstellung von Piperazinderivaten
DE1795375A1 (de) * 1968-09-21 1972-01-05 Boehringer Mannheim Gmbh Basische AEther und Verfahren zur Herstellung derselben
JPS504086A (xx) * 1973-01-18 1975-01-16

Also Published As

Publication number Publication date
PT67400A (en) 1978-01-01
NZ185981A (en) 1980-02-21
DK147421B (da) 1984-07-30
AU516920B2 (en) 1981-07-02
JPS6215546B2 (xx) 1987-04-08
ATA891177A (de) 1980-12-15
NO148150C (no) 1983-08-24
AU3157377A (en) 1979-06-21
JPS5382789A (en) 1978-07-21
GB1545094A (en) 1979-05-02
ZA777452B (en) 1978-10-25
FI773786A (fi) 1978-06-15
ES473816A1 (es) 1979-04-16
ES473815A1 (es) 1979-05-01
ES473817A1 (es) 1979-04-16
DK147421C (da) 1985-02-11
US4265894A (en) 1981-05-05
ES473818A1 (es) 1979-04-16
BE861853A (fr) 1978-06-14
IE46278B1 (en) 1983-04-20
SE7714184L (sv) 1978-06-15
PT67400B (en) 1979-05-21
IE46278L (en) 1978-06-14
SE435378B (sv) 1984-09-24
DE2755752A1 (de) 1978-06-15
NO774307L (no) 1978-06-15
ES465047A1 (es) 1979-01-01
IT1093045B (it) 1985-07-19
LU78686A1 (xx) 1978-04-17
DK557277A (da) 1978-06-15
IL53597A0 (en) 1978-03-10
HU177999B (en) 1982-02-27
NL7713817A (nl) 1978-06-16
FI69839B (fi) 1985-12-31
AT363090B (de) 1981-07-10
ES473814A1 (es) 1979-04-16
DE2755752C2 (xx) 1991-12-05
FI69839C (fi) 1986-05-26
US4202896A (en) 1980-05-13
NO148150B (no) 1983-05-09

Similar Documents

Publication Publication Date Title
YU295877A (en) Process for obtaining therepeutically active piperazine derivatives
YU40701B (en) Process for obtaining morpholine derivatives
BG36044A3 (en) Method for preparing piperazine derivatives
HU172711B (hu) Sposob poluchenija proizvodnykh piperidil-indola
PT66713A (en) Process for preparing 4-hydroxyphenylalkanolamine derivatives
YU42888B (en) Process for obtaining indolysine derivatives
HU178040B (en) Process for preparing 8-aza-prostaglandin derivatives
GB1550545A (en) Piperazine derivatives
HU173606B (hu) Sposob poluchenija proizvodnykh benzo-sul'fo-karbamida
YU94877A (en) Process for obtaining naphthiridine derivatives
HU178806B (en) Process for preparing benzyl-cyano-acetal derivatives
YU104477A (en) Process for obtaining phenyl piperazine derivatives
YU293677A (en) Process for obtaining new piperazine derivatives
YU39669B (en) Process for obtaining triphenylalkene derivatives
HU174982B (hu) Sposob poluchenija proizvodnykh 17al'fa-gidroksi-pregnan-20-ona
YU40169B (en) Process for obtaining thiochromane derivatives
YU20577A (en) Process for obtaining triphenylalkene derivatives
YU141877A (en) Process for obtaining hydrazinopyridazine derivatives
YU40303B (en) Process for obtaining new nitroalkanol derivatives
HU177936B (en) Process for preparing 1-dialkylamino-2-alkin-4-ol derivatives
HU176954B (hu) Sposob poluchenija proizvodnykh cis-geksagidro-dibenzopiranona
YU70177A (en) Process for preparing sandwicin derivatives
HU183632B (en) Process for preparing 4-thioxy-2-azetidinone derivatives
CS193538B2 (en) Process for preparing derivatives n-aminoalkyl-n-phenyl--2-aminoindane
YU189182A (en) Process for obtaining therapeutically active piperazine derivatives